Genpharmasec Ltd
BSE:531592
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Genpharmasec Ltd
BSE:531592
|
IN |
|
Y
|
Yorkey Optical International (Cayman) Ltd
HKEX:2788
|
HK |
|
Samwha Electronics Co Ltd
KRX:011230
|
KR |
|
Nichias Corp
TSE:5393
|
JP |
|
Star Diamond Corp
TSX:DIAM
|
CA |
|
Ggtoor Inc
OTC:GTOR
|
US |
|
L
|
Live Oak Bancshares Inc
NYSE:LOB
|
US |
|
Brain Scientific Inc
OTC:BRSF
|
US |
|
KPIT Technologies Ltd
NSE:KPITTECH
|
IN |
|
Aukett Swanke Group PLC
LSE:AUK
|
UK |
|
R
|
Reliq Health Technologies Inc
SWB:MHN2
|
CA |
Shareholder Yield
Current shareholder yield for GENPHARMA is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
GENPHARMA Price
Genpharmasec Ltd
| Average Annual Return | -7.3% |
| Standard Deviation of Annual Returns | 28.2% |
| Max Drawdown | -87% |
| Market Capitalization | 503.9m INR |
| Shares Outstanding | 553 720 000 |
| Percentage of Shares Shorted |
N/A
|
GENPHARMA Return Decomposition
Main factors of price return
Stock Splits
GENPHARMA's latest stock split occurred on Jan 9, 2024
The company executed a 871-for-523 stock split, meaning that for every 523 shares held, investors received 871 new shares.
Before the split, GENPHARMA traded at 8.71 per share. Afterward, the share price was about 5.75.
The adjusted shares began trading on Jan 9, 2024. This was GENPHARMA's 3rd stock split, following the previous one in Apr 11, 2019.
